Target intelligence / Profile preview

Klebsiella pneumoniae surface antigen

Molecular classification
Polysaccharide, Lipopolysaccharide, Outer membrane protein, Other
01

Overview

Klebsiella pneumoniae surface antigens are a collection of immunogenic molecules located on the bacterial exterior, primarily consisting of the capsular polysaccharide (K antigen), lipopolysaccharide (O antigen), and various outer membrane proteins (OMPs) (Podschun & Ullmann, 1998). These components are essential for the pathogen's survival and virulence within the host; the capsule acts as a protective shield against phagocytosis and complement-mediated lysis, while the O-antigen provides resistance to the bactericidal activity of serum (Bengoechea & Sa Pessoa, 2019). As therapeutic targets, these antigens are the focus of vaccine development and monoclonal antibody therapies designed to treat infections caused by multi-drug resistant (MDR) strains (Choi et al., 2020). For example, the monoclonal antibody AR-401 targets the O-antigen to promote opsonophagocytic killing by host immune cells (Aridis Pharmaceuticals). A significant challenge in targeting these antigens is their high structural diversity, particularly the existence of over 77 distinct K-serotypes, which requires the use of multivalent or broadly cross-reactive therapeutic agents (Vaxcyte, 2023).

Other names
Klebsiella pneumoniae antigensCapsular polysaccharide (K antigen)Lipopolysaccharide (O antigen)Outer membrane proteins (OMPs)K. pneumoniae surface components
02

Mechanism of action

Enhancement of opsonophagocytosis and neutralization of bacterial virulence factors

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Serotype replacement (vaccine escape)Endotoxin-related inflammatory responseLimited serotype coverage
06

Interacting drugs

AR-401

2 more in the full profile.

07

Biomarkers

Serotype-specific antibody titersC-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Klebsiella pneumoniae surface antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klebsiella pneumoniae surface antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call